Envestnet Portfolio Solutions’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,121
Closed -$252K – 1426
2026
Q1
$252K Sell
1,121
-621
-36% -$155K ﹤0.01% 1186
2025
Q4
$420K Buy
1,742
+540
+45% +$138K ﹤0.01% 1131
2025
Q3
$329K Sell
1,202
-2,385
-66% -$651K ﹤0.01% 1200
2025
Q2
$925K Sell
3,587
-1,458
-29% -$348K ﹤0.01% 822
2025
Q1
$1.13M Sell
5,045
-972
-16% -$227K ﹤0.01% 752
2024
Q4
$1.38M Buy
6,017
+3,678
+157% +$886K ﹤0.01% 798
2024
Q3
$571K Sell
2,339
-514
-18% -$115K ﹤0.01% 1129
2024
Q2
$546K Sell
2,853
-335
-11% -$68K ﹤0.01% 1104
2024
Q1
$631K Buy
3,188
+60
+2% +$11K ﹤0.01% 1014
2023
Q4
$538K Buy
3,128
+171
+6% +$26.3K ﹤0.01% 1017
2023
Q3
$437K Buy
+2,957
New +$535K ﹤0.01% 1042

Other funds holding RMD

Envestnet Portfolio Solutions's RMD Position: Q2 2026 in Review

Envestnet Portfolio Solutions sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,121 shares — an estimated $252K sold.

Envestnet Portfolio Solutions first reported a position in RMD in Q3 2023 and held it in 11 quarters. The position peaked at $1.38M in Q4 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Envestnet Portfolio Solutions reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 1,121 ResMed shares in Q2 2026, an estimated $252K.
  • Envestnet Portfolio Solutions first reported a position in ResMed in Q3 2023 and held it in 11 quarters.
  • Envestnet Portfolio Solutions's ResMed position peaked at $1.38M in Q4 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.